Search results
Sanofi heads out to surf Belharra in $700M biobucks immunology deal
FierceBiotech· 4 days agoSanofi is offering Belharra Therapeutics up to $700 million in biobucks for a tow out to surf the...
Sanofi and Biovac partner to produce polio vaccines in Africa
Pharmaceutical Technology via Yahoo Finance· 22 hours agoSanofi and Biovac have announced a partnership to establish the first African-based manufacturing...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 15 hours agoBut the competitor vaccines have full FDA approval. Meanwhile, Novavax's shot has been available in...
The secrets of success with Paul Hudson, CEO of Sanofi, the leader who’s channeling AI to find the...
Fortune via AOL· 2 days agoWe look into the lives, minds and agendas of CEOs at the world's most iconic companies. Paul Hudson,...
Cwm LLC Has $6.44 Million Stock Position in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 2 days agoCwm LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 1.7% during the 1st quarter, according to its most recent disclosure with the Securities and ...
Sanofi and Belharra forge $700m partnership for immunological diseases
Pharmaceutical Technology via Yahoo Finance· 4 days agoBelharra Therapeutics has announced that it has entered a strategic partnership with global...
9,852 Shares in Sanofi (NASDAQ:SNY) Acquired by V Square Quantitative Management LLC
ETF DAILY NEWS· 6 days agoV Square Quantitative Management LLC purchased a new position in Sanofi (NASDAQ:SNY – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor ...
Fisher Asset Management LLC Lowers Stock Holdings in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 5 days agoFisher Asset Management LLC lessened its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.4% in the 4th quarter, according to its most recent disclosure with the ...
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 4 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Sanofi (OTCMKTS:SNYNF) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 5 days agoSanofi (OTCMKTS:SNYNF – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 290,700 shares, a ...